Survival curves from the Comfort Trials ASH abstract look terrific
Although INCY will not be allowed by the FDA to specifically claim that JAKAFI prolongs life, publishing the graphs will speak for itself. It is likely that the separation between the JAKAFI survival curve and best standard care survrival curve will further separate over time.
Great news for the folks with this dreaded disease! One of these days the idiots on wall street will take notice Until then we put up with Viselinger and TJ. Viselinger, what is your take on the latest ASH abstract?